Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2 Study Targeting Acquired Resistance Mechanisms in Patients With EGFR Mutant Non-Small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04862780
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:52.690105+00:00
Published At
2025-02-10T00:00:00+00:00
Record Updated At
2025-02-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lung Neoplasms", "Carcinoma, Non-Small-Cell Lung", "Respiratory Tract Neoplasms", "Neoplasms", "Neoplasms by Site", "Lung Diseases", "Respiratory Tract Disease", "Carcinoma, Bronchogenic", "Bronchial Neoplasms", "Adenocarcinoma", "Carcinoma", "Neoplasms by Histologic Type", "Neoplasms, Nerve Tissue", "EGFR T790M", "EGFR C797S", "EGFR L858R", "EGFR Gene Mutation", "EGF-R Positive Non-Small Cell Lung Cancer", "EGFR Exon 19 Deletion", "EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Resistance", "EGFR Activating Mutation", "Protein Kinase Inhibitors", "Antineoplastic Agents", "Thoracic Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-02-10"
protocolSection.identificationModule.nctId
"NCT04862780"
protocolSection.identificationModule.officialTitle
"A Phase 1/2 Study Targeting Acquired Resistance Mechanisms in Patients With EGFR Mutant Non-Small Cell Lung Cancer"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Lung Neoplasms (protocolSection.conditionsModule.conditions)
  • Carcinoma, Non-Small-Cell Lung (protocolSection.conditionsModule.conditions)
  • Respiratory Tract Neoplasms (protocolSection.conditionsModule.conditions)
  • Neoplasms (protocolSection.conditionsModule.conditions)
  • Neoplasms by Site (protocolSection.conditionsModule.conditions)
  • Lung Diseases (protocolSection.conditionsModule.conditions)
  • Respiratory Tract Disease (protocolSection.conditionsModule.conditions)
  • Carcinoma, Bronchogenic (protocolSection.conditionsModule.conditions)
  • Bronchial Neoplasms (protocolSection.conditionsModule.conditions)
  • Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Carcinoma (protocolSection.conditionsModule.conditions)
  • Neoplasms by Histologic Type (protocolSection.conditionsModule.conditions)
  • Neoplasms, Nerve Tissue (protocolSection.conditionsModule.conditions)
  • EGFR T790M (protocolSection.conditionsModule.conditions)
  • EGFR C797S (protocolSection.conditionsModule.conditions)
  • EGFR L858R (protocolSection.conditionsModule.conditions)
  • EGFR Gene Mutation (protocolSection.conditionsModule.conditions)
  • EGF-R Positive Non-Small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
  • EGFR Exon 19 Deletion (protocolSection.conditionsModule.conditions)
  • EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Resistance (protocolSection.conditionsModule.conditions)
  • EGFR Activating Mutation (protocolSection.conditionsModule.conditions)
  • Protein Kinase Inhibitors (protocolSection.conditionsModule.conditions)
  • Antineoplastic Agents (protocolSection.conditionsModule.conditions)
  • Thoracic Neoplasms (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.